Philman's Pharm: "German Quality, California Ingenuity." Est. 1977

24 countries where cannabis is legal

Israel – God’s own country is on its way to decriminalize the use of *weed* for self pleasure.

According to reports, it is estimated that 9% of the population in Israel use weed. With the decriminalisation of weed which was announced by Public Security Minister Gilad Erdan, Israelis will be allowed to possess up to 15 grammes of weed.

If a first timer is caught possessing over the stipulated limit he or she would pay a fine of 1000 shekels (roughly N122,000). This will also not show up on the person’s record.

Israel is one of the leading countries in medical weed research. The country has joined other countries in Europe and North America to decriminalise or legalise cannabis.

1. Mexico’s Supreme Court ruled in 2015 that growing, possessing and smoking weed for recreation is legal under the right to freedom.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

The measure was approved in 4-1 vote on the five-justice panel, backing the argument that smoking weed is covered under the right of “free development of personality.”

Here’s a quick look at 26 countries where weed is legal and what the law states:

2. Czech Republic

Czech Republic permits possession of up to 15 grams for personal use. Weed for medical use on prescription has been legalised since April 2013.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

3. Switzerland

According to Switzerland laws, growing weed on private property for personal consumption by adults is legal. However, buying or selling weed is a strict criminal offence and punishable by a fine.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

In 2013, the mountainous Central European country decriminalized weed for people over 18 with 10 grams or less of the drug. There’s still a fine if you’re caught — about $110 — but it doesn’t go on your permanent record and you don’t have to make a court appearance.

But with the country’s high salaries, that works out to quite a cheap fine. You’ll still want to smoke in private, though; taking the drug is illegal and can result in much higher fines, especially if you’re a repeat offender.

4. North Korea

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Surprising as it may seem, but the growth, sale and consumption of weed in the communist country is legal and widely unregulated by the government. Just remember it’s North Korea!

5. Uruguay

While Uruguayan President Jose Mujica has legalised Cannabis, you need to be over 18 years of age to buy it. The law states that to buy people should be residents of the country, above 18 years of age and must register with the authorities.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Besides, there isn’t any law as of yet that specifies the quantity or mandated any rules for selling, transporting or cultivating weed.

6. Argentina

Possession of Cannabis is illegal, but decriminalised. It is legal for personal consumption in small quantities inside a private property.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

While consumption for medical reasons is acceptable within a private property, sale, transportation and cultivation is illegal by law.

7. Jamaica

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Growing, selling and consuming weed is illegal. But it’s been decriminalised in 2013 if a person is found with a small amount.

8. Spain

Spain has a complicated system of drug laws, but weed is not criminalized as long as you smoke in private. Since the ’90s, if you are caught with banned substances in public, you won’t be punished by jail time, but you might get a hefty fine of about $330.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

You can grow two plants for personal use, but buying or carrying is still illegal. In a creative way around these seemingly contradictory laws, “private clubs” have flourished. In cities like Barcelona, you can easily join a members-only pot club where you can smoke your own weed or buy some of theirs.

Tourists, beware, though. The regional government has tried to stymie weed tourism by limiting membership to Spanish residents.

9. Portugal

Portugal has decriminalized possession and consumption of all dr*gs, as long as you don’t have more than a 10-day supply. If you’re caught with this small amount you can be sent to a treatment center or be forced to a pay a fine.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

A three-person committee decides your fate, but often there is no penalty. In addition to benefiting weed users, that 2014 European Monitoring Center for Dr*gs and Drug Addiction Policy report showed that the law has led to a reduction in drug deaths and HIV cases.

10. Australia

Much like the US, Australia has decriminalized weed in some states but opted to keep it a more substantially-punishable offense in others.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

With their natural proclivity to co-exist with crocs, Russell Crowe, and other nightmarish animals, you’d think they wouldn’t be afraid of a little old fashioned relaxation.

11. Belgium

As far as legality, it’s only allowed if you only grow one bedrocan female plant and nothing else.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Possession has been made illegal again—so that means you just have to hang on to that one female plant.

12. Cambodia

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

The use of weed is widespread among the Khmer people and foreigners alike—there are even places designated as “Happy Restaurants” in Phnom Penh, Siem Reap and Sihanoukville that publicly offer food cooked with weed.

13. Canada

You have to try really hard to get in trouble for anything in Canada.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

The least of which is smoking weed. You can probably walk down their one highway smoking a joint, playing Springsteen, and shouting “USA! USA!” and all that’ll happen is a passerby will likely offer you a ride.

14. Columbia

Pot has actually been decriminalized in Columbia since 1994 and up to 22 grams is fine under the eyes of the law.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

However, if you’re caught with over 20 plants—which is a bit much—you will have to face some unpleasant music.

15. Costa Rica

A de facto decriminalization policy of possession has been upheld throughout the country, and there’s no minimum or maximum amount assigned as of yet.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Just another nugget of gold from the chill country that has sloths and sharks on its money.

16. Croatia

Selling cannabis in Croatia is punishable by a mandatory prison sentence of three years—so that’s out, but possessing a small amount of the drug is only met with a light fine.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

17. Ecuador

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Ten grams is the legal limit in Ecuador, whereas selling, cultivating or transporting the stuff will get you in serious trouble.

18. Estonia

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Pro-tip: stick to the 7.5 gram possession limit or you’ll end up spending five years in an Estonian jail. Do you want that? Didn’t think so.

19. Nepal

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Pot is nothing new to Nepal. They’ve used the plant for centuries, mostly in religious rituals that involve either drinking an infused beverage, smoking the buds, or harvesting and smoking the resin (hash).

20. Netherlands

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Fully legal in designated smoking areas (those coffee shops you always hear about), weed is almost legal across the board, but selling and transporting the stuff will cause problems.

21. Pakistan

Pakistan is tricky, because the “legality” relies on the laziness of the local police force—while it’s illegal to posses pot, it’s widely tolerated.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

However, cultivating *weed* has been decriminalized, which explains the large tracts of cannabis growing freely throughout the country.

22. Peru

You can grow it. You can drive around with it. You can smoke it. Hell, you can do whatever you want with it. Except sell it. Definitely don’t do that.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

23. Russia

Of course you can smoke pot in Russia.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Just make sure you don’t have more than six grams, or you’ll totally go to Siberia.

24. Ukraine

It’s fully illegal to sell pot—don’t do that in the Ukraine. However, possessing up to five grams or ten plants is A-OK.

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Weed Smoking! Top 26 countries where weed is legal (Pictured)

Given the state-by-state policy in the United States, there are states that are both way ahead of the international movement towards legalization and way behind. So if your travel budget won’t quite stretch to Europe or South America, consider a domestic flight to Washington, Colorado, Oregon, or Alaska.

In Nigeria, weed must never be found in your possession, neither should you be caught smoking it. This for many is not progressive at all and they would rather have the government a second look at the law that prohibits the people from coming close to weed.


The World Commission on Drug Policy calls for the decriminalization

Decriminalization The Global Commission on Drug Policy, which is leading from 23 politicians and leading intellectuals, has submitted its annual report 2016th It calls for a worldwide decriminalization of all drugs and the abolition of all sanctions which are still being imposed on the consumption and possession of drugs in large parts of the world.

On November 21, 2016, presented the Global Commission on Drug Policy at a press conference in Washington its annual report, entitled Advancing Drug Reform: New Approach to Drug Decriminalization (Other drug policy reform: A New Approach to decriminalize drugs). The Commission’s experts and leading figures in the world are discussing their recommendations in the field of drug policy, and the need to decriminalize the possession and consumption of narcotic drugs even before a global regulation of drug markets.

This annual report is based on the five previously published annual reports, in which the Commission called on the governments of the States and the United Nations, as well as the public, to change their perception of drug users and to counter the prejudices against them.

The Annual Report 2016 (the press conference, you can here view) recommend to the States, a charge regulation and ending the harsh prosecution of the consumption and possession of drugs, which has led to a variety of people around the world to damage and prejudice; .

“Only in this way,” says the annual report, “can the progressive destruction of society be permanently mitigated by drug prohibition”.

The World Commission on Drug Policy and its Mission

Since its founding just six years ago in 2011, the commission has commissioned a reorientation of the discussion on the reform of drug policies to make them more balanced and based on facts and evidence, as well as strict respect for human rights and the emphasis on aspects Public health, social inclusion and security.

Kofi Annan, ex-general secretary of the UNO and a member of the Commission
Kofi Annan, former General Secretary of the United Nations and a member of the Commission (CC United States Mission Geneva)

The World Commission – consisting of 25 politicians, famous artists and influential figures of the financial and corporate world – is an independent body that wants to be a world reference for drug policy reform by protecting recommendations for innovative and effective political Maßnahmenausspricht that human rights , Reduce health damage and promote social development.

Among the members of the Commission are the former Secretary-General of the United Nations, Kofi Annan, the former Presidents of Colombia, Mexico, Chile, Brazil, Nigeria, Greece, former Prime Ministers from Poland, Portugal and Switzerland; The British multimillionaire and philanthropist Sir Richard Branson; George Schultz, former US Secretary of State under Reagan; The Nobel Prize in Literature Mario Vargas Llosa; The Spaniard Javier Solana, former EU Commissioner for the Community’s foreign and security policy; Nick Clegg, former UK Deputy Prime Minister and Member of Parliament, as well as other prominent human rights activists and personalities.

The World Commission, which chaired the Alt Federal Councillor of Switzerland Ruth Dreifuss is, by a secretary at the Institute de Hautes Études Internationales Et Du Dévelopment supported in Switzerland, which is responsible for the publications of the Commission, among other things. The Commission also establishes, on a ad-hoc basis, a network of thematic experts who make important contributions from their home Member States.

Since its inception, the World Commission has produced five main reports and three documentary films distributed throughout the world, addressing problems such as the failed war on drugs, the impact of its criminalization on public health, and the possible ways of effective drug regulation.

For the World Commission was as early as 2012 with the Cannabis Culture Awards awarded, contrary took the Sir Richard Branson and former Norwegian Foreign Minister Thorvald Stoltenberg on behalf of the Commission. This prestigious award, which was initiated by the Sensi-founder Ben Dronkers back is awarded annually in thanks and recognition to individuals and organizations who advocate a paradigm shift and contribute towards changing the public perception of cannabis. These are people of public life, who criticize the war against drugs, oppose it and prove their courage in the fight for a complete acceptance of the cannabis plant.

Reports and recommendations

The first, in 2011 created and published Commission report began with the words: “The global war on drugs has failed, with devastating consequences for individuals and societies around the world”, and sets out in the following that the current global strategy In drug policy has not developed and therefore a new approach is needed.

The chairman of the commission is Ruth Dreifuss, the first female Federal Councilor of Switzerland
The chairman of the commission is Ruth Dreifuss, the first female Federal Councilor of Switzerland (CC Utenriksdepartementet UD)

This was the first time that celebrities from politics, intellectuals and senior diplomats have publicly expressed what the cannabis activism for years denounced: The war on drugs has failed, on the whole line.

The Commission recommended the following strategy: the decriminalization of all drugs, the provision of care and health services for all persons in need, and mitigation measures, such as substitution therapy. Repressive measures, on the other hand, should be confined exclusively to violent criminal organizations in order to limit their power and influence.

2016: A new start for decriminalization

Over the five years of activity of Kommissionhat global drug policy experienced major price changes, both in the public debate and opinion as well as in scientific terms . But noteworthy is the implementation of new policy approaches , the experiment concretely with different ways to regulate the cannabis market, as well as alternatives to the criminalization of drug users.

These reforms are on the way, but the prohibition policy is still officially maintained and in the name of the war against the drugs continues to favor human rights violations.

Since the publication of its first report, the Commission has called for the systematic decriminalization of all drugs in all its publications. However, this year’s report goes one step further and opens new avenues for a new understanding of the effective decriminalization of drugs.

In its annual report 2016, the World Commission on Drugs Policy recommends that the governments of the States abandon both the criminal and all other sanctions for the consumption and possession of drugs and urgently abolish the death penalty for any kind of offenses related to drugs (including self-use) Of narcotics), in all 33 countries, where this punishment still applies.

“The World Commission thinks that the possession of small quantities and / or their own consumption can not be punished at all, while respecting human dignity and the rule of law,” the annual report says.

The Spanish politician and diplomat Javier Solana
The Spanish politician and diplomat Javier Solana (CC.Security & Defense Agenda)

The document refers in particular to the effective Entkriminalisierungspolitik, the thirteen years as Portugal takes place, where the possession of drugs (including cannabis) is not a criminal offense, which has led there to a lower number of addicts and overdose deaths and of deaths of sexually transmitted diseases.

As the former mayor of Prague, Pavel Bém, at the press conference said, Portugal is therefore a good example because there thanks to the decline of offenders 18% of government spending were saved for prisons, since the personal use of illicit substances is provided impunity 2,001th

Criticized in particular in countries such as the Philippines practiced penalties for drug offenses, which have led to the killing of thousands of drug addicts and -dealer without any judicial process, especially since the election of Rodrigo Duterte for President, who even asks the public, with the ” Eradication “of drug addicts and dementia.

“The countries that are most concerned about us are in Asia. It is a group of nations that prescribe a radical interpretation of the Shari’ah, that is, the Islamic law. If you also China accepts it, we are dealing with a large part of the world, we still have to convince them that the death penalty violates human rights “, Dreifuss summed up the Commission’s recommendations together.

The Commission’s annual report calls for decriminalization and impunity, both administrative and criminal, for all persons who are only marginally involved in drug trafficking. This also applies to drug traffickers who finance their own needs through trade, transporters without a criminal record for acts of violence such as drug traffickers and illegal drug cultivation. At the same time, the States must create alternatives to the punishment of non-violent actors, who are only marginally involved in drug trafficking.

For many of these people, according to the annual report, these activities are devoted only to “economic distress”, “lack of alternatives” or “because they are forced to do so”. And despite their awkward social situation, such people are then confronted with harsh penalties ranging from high fines to the destruction of the plantations and prison sentences securing their livelihood, to the death penalty (in some states). Meanwhile, to the beneficiaries of the prohibition of drugs such as cannabis further retract their profits.

“For years, we have put the dramatic effects of the ban on society as a whole, and in particular the criminalization of people, who merely consume drugs and do no harm to others. Today, we see the time to bring the benefits of a well-designed and human-oriented drug policy to the fore, “said Commission President Ruth Dreifuss at the presentation of the annual report.

According to the annual report, the implementation of such innovative policy approaches must be preceded by an honest debate on the root cause of past drug policies, ie the criminalization of the own needs or possession of psychoactive substances prohibited by national legislation. The aim should be a complete decriminalization, including the lifting of fines and other criminal sanctions: “States that renew their drug laws should try to implement this model,” the report said.

The fourth recommendation states that the UN states should abolish the criminalization of possession of drugs as a treaty under the international drug control regime.

The Commission criticized vehemently that the contracts or agreements of the UN drug control regime have created the space for a national policy that is contrary to the Declaration of Human Rights of the United Nations: For 5.5 billion people around the world have no or Scarce access to adequate drugs for pain relief solely because of the restrictions in the prescription of opium-containing painkillers or analgesic narcotics.

Even the United Nations Office on Drugs and Crime (UNODC) itself has a short report created in which it is explained that the impunity for the use and possession of drugs is compatible for their own use with the contracts of the international drug control regime. This document also informs the States about the solutions to human rights-based drug policies and to improving public health.

Richard Branson receives the Cannabis Culture Award in the name of the World Commission on Drug Policy in 2012 (CC.Unclimatechange)
Richard Branson receives the Cannabis Culture Award in the name of the World Commission on Drug Policy in 2012 (CC.Unclimatechange)

Nevertheless, once again the inaction of the United Nations in the fight against drug abuse became apparent when the last special session of the UN General Assembly ( UNGASS ) in New York in April 2016 took place. This supposedly revolutionary meeting, which should initiate a global change of direction in drug policy, explained only the large gap between the States and ended with a non-binding framework agreement that had been negotiated months before the summit, instead of far-reaching reforms, whose greatest enemy among others Russia Was.

As a result, Richard Branson, a member of the World Commission on Drug Policy, described the last UNGASS meeting in the British newspaper The Guardian as “a process that was flawed from the outset”. And he added that the document she had adopted was a party to the law, and only to the interests of 53 states, but not to all of the 193 UN Member States.

Finally, the annual report recommends that the States must discuss and recognize regulatory models for all illicit drugs as this is the next major step in the reform of drug policies after decriminalization.

“Drug policy is developing at a global, regional or local level,” said Commissioner César Gaviria (former President of Colombia). “In order to develop a sound and effective policy that mitigates the damage of the last 60 years of false policy and to prepare for a better future in which drugs can be controlled more effectively, we must implement a complete decriminalization of own resources without any discretion.”

For the Commission the decriminalization or impunity is the first and indispensable big step in the right direction to reform drug policies at the global level, as with the legalization of cannabis has been done in many countries. As a second step, the state regulation of all markets for illegal drugs must follow, from production to distribution.

The Commission is aware of the fact that its recommendations are expressed in the midst of a change in the political climate, which may also have detrimental effects on decriminalization. However, as the result of the recent US elections showed that voters in spite of the electoral triumph of Donald Trump in the race for the presidency yet for legalizing cannabis than tobacco in three other states and for legislation on medical cannabis in four other states pronounced.

In any case, drug policy should be strictly separated from any conservative party politics, so that the latter can not interfere with efforts to impunity for drugs in general and specifically for cannabis. It is becoming increasingly clear to citizens that this issue is about human rights and that there is no reason why the state should interfere with the lives of millions of people who consume a particular type of drug as a luxury or a medical condition, Without harming anyone else with it.

We hope that the recommendations of the World Commission on Drug Policy will not fall on deaf ears, and the governments of the various countries of the world will consider them for a realistic analysis of what is happening in the practice of international drug policy, not in the rhetoric of populism and party politics Has proved successful or failed. At the moment, emotions and ideologies still have more weight than evidence and facts.

CanniMed Therapeutics, Cronos Group, Aphria, And Canopy Growth Shares Ignited By Germany’s Medical Marijuana Law ……Written By: James West

CanniMed Therapeutics Inc (TSE:CMED)(OTCMKTS:CMMDF)(FRA:0GB) , Cronos Group(CVE:MJN)(OTCMKTS:PRMCF) , Aphria Inc (CVE:APH) (OTCMKTS:APHQF) andCanopy Growth Corp (TSE:CGC) (OTCMKTS:TWMJF) (FRA:11L1) are among the most heavily traded stocks on their respective Canadian exchanges in the last few days, and the cause is rooted in Germany. The German parliament voted unanimously to pass the “cannabis as medicine” law, which takes effect in March of 2017.

German Federal Minister of Health Hermann Gröhe said in a statement, “People with disabilities need the best possible treatment, and shouldn’t have to resort to drug traffickers if that means cannabis, which will be covered by health insurance.”

Parliamentary secretary Ingrid Fischbach added, “For serious illnesses that cause chronic pain like multiple sclerosis, cannabis in medicinal form helps alleviate those symptoms.”

There is potentially a 230% bump in revenue for Canadian ACMPR growers as a result of the German medical market coming on stream.

The statement concluded that the availability of cannabis in Germany would be through imports until “state-controlled cultivation” can be established.

Germany has a population of 80 million people, and Canada, 35 million. At the end of September 2016, there were 98,460 registered clients who had consumed 4,773 kilograms of marijuana and 2,420 kilograms of cannabis oil. That suggests, if there 2.3 more Germans than Canadians, an increased marketplace totalling 15,750 kilograms of dried bud and 7,986 kilograms of oil.

Or, in simpler terms, there is potentially a 230% bump in revenue for Canadian ACMPR growers as a result of the German medical market coming on stream.

Canadian Cannabis Companies poised to benefit

Some of Canada’s leading Access to Cannabis for Medical Purposes Regulation (ACMPR)-accredited companies applauded the development, as they are already positioned to be a source of medical cannabis for Germans. With the population of Germany roughly double that of Canada, the development represents access to another market that is likely to be worth twice what Canada’s is.

Cronos Group moved to position itself to access the German market serendipitously in October 2016, announcing its wholly owned subsidiary, Peace Naturals Project Inc, had shipped its first export of premium medicinal marijuana to Germany.

“This export marks an important milestone in Cronos Group’s strategic global expansion and the beginning of a long, fruitful relationship between Peace and Pedanios GmbH,” said Mike Gorenstein, Cronos Group’s CEO.

Listen to the podcast interview with Mike Gorenstein:

Audio Player

In a recent Midas Letter podcast interview, he said “I think it’s going to be a ramp-up, but as far as the [German] medicinal market, we project it will be larger than the Canadian market. I think that the combination of having insurance coverage, it’s really when you compare issues in new medical markets to the black market, why do you go to the trouble of going to see a doctor and get a script and this process of then having to find an LP and register, but with insurance coverage, it makes a lot of sense.”

CanniMed Therapeutics is also well-positioned to ship its products to German patients through its relationship with Australian publicly traded Creso Pharma Ltd. (ASX:CPH), who it appointed as its representative “in the European Union for the purpose of marketing all CanniMed® medical cannabis brands to governments, authorized importers and distributors, institutions, pharmacies and individuals.”

Listen to the podcast interview with Brent Zettl:

Audio Player

CEO Brent Zettl told us in a Midas Letter Podcast Interview that “we have eight countries that we’re speaking with at various levels, and those discussions are all ongoing, and we expect to see something happening in early sales provided that the licensing amendments come through as we need, and then we’ll start to see how that propels. So we think it’s going to, we’re going to have a very strong 2017.”

Bruce Linton, CEO of Canopy Growth Corp, which owns the Tweed, Vert, Bedrocan and also has a takeover bid underway for Mettrum, thinks their strategy will actually be to establish growing operations inside Germany, while supplying Germans patients from Canadian-grown supplies until the industry there is ready.

Listen to the podcast interview with Bruce Linton:

Audio Player

“It worked for bottling lines for Coca-Cola as an expansion process,” he said. “Our intent though is, in most countries, to go in where it’s 100 percent corporate store, which is why in November, we acquired the company that had been our export partner, so we actually have our boots on the ground in Germany to work through the process rather than, you know, a JV and everybody’s not aligned.”

Aphria isn’t shipping product to Germany at this point, but CEO Vic Neufeld says the company is definitely going to be a player in Europe.

Midas-Letter-financial-radio-podcast-thumbListen to the podcast interview with Vic Neufeld:

Audio Player

“Germany is absolutely most recently very much on our radar,” he told us during a Midas Letter podcast interview. “and we are engaged in dialogue with two different organizations, but we haven’t got to anything formal like a letter of intent.”

Israeli government to finance 13 cannabis research projects


Israel’s Agriculture and Rural Development Ministry plans to spend 8 million shekels ($2.1 million) on research into cannabis cultivation, biochemistry and medicine.

The government is hopeful the research will lead to cannabis-based therapeutic products, the Times of Israel reported.

To start, the ministry is financing 13 projects, including seven in the fields of biochemistry and medicine.

Research topics include how cannabis can improve vision, fight colon cancer and treat multiple sclerosis, according to The Jerusalem Post. Other research projects will explore such issues as whether cannabis can help the body accept transplanted organs and treat metabolic syndrome.

The other six research projects will focus on cultivation, including the development of irrigation and fertilization technologies, fighting pests and diseases that can damage cannabis plants, and improving planting and reproduction techniques. The funds will also be used to establish a national genetic database for medical cannabis plants, the Jerusalem Post reported.

This investment is another example why Israel is considered a hub for medical marijuana exploration.

CEO Bruce Linton of Canopy Growth -on the opportunity for Canadian cannabis exports…..in Germany

Written By:  January 23, 2017

Canopy Growth Corp’s Bruce Linton on Germany’s Cannabis Future

Canopy Growth Corp (TSE:CGC) (OTCMKTS:TWMJF) (FRA:11L1) CEO Bruce Linton returns to share his thoughts on the opportunity for Canadian cannabis exports that exists in the gradual spread of legal medical marijuana rules in Germany and beyond. He also shares his views on potential incoming Attorney General Jeff Sessions, and how that might actually turn out to be a boon for Canadian growers as well.

Midas-Letter-financial-radio-podcast-thumbListen to the podcast interview with Bruce Linton:

Audio Player



James West:    Thanks for joining us today, Bruce.

Bruce Linton:  Hey, thanks for having me back, James.

James West:    Bruce, let’s cover a couple of things today. First, let’s talk about Germany’s approval of medical marijuana coverage by insurance companies. That’s a new development for you guys, and I’m sure it’s going to have some implications for 2017 revenue. What do you think about that?

Bruce Linton:  Yeah, so you know, this has kind of been the slow build, and where it comes from, and if people are looking at other countries as well as Germany, it starts by somebody in a country establishing something called the OMC, or Office of Medical Cannabis, which is almost like an indicator that in fact, in the future, there’s likely going to be cannabis available. That happened in Germany some time ago. We knew, and you could see, that these regs were moving through their Parliamentary process, and it appears the next steps are to do a German thing, which is almost like a public reading of them, and then they become how they reorganize or organize the appropriate bureaucracy, and then they’re ready to go.

So I kind of think by March or end of March, they’ll be through those steps, and then they’re going to start saying we need more product, and we need more producers. They currently have no producers in the country, so that’s, I think, why it keeps getting more interesting.

James West:    Sure. Would Canopy look to set up production within Germany’s borders, or just look to exploit it from an export position?

Bruce Linton:  NO, listen man, I come at this from the perspective of, the reason Smiths Falls in Ontario loves us is, we took the abandoned chocolate factory and turned it into a centre of employment. They don’t perceive anything about what we do other than that; it is creating employment, and there are big parts of Germany where they haven’t had the benefit of the boom. So I would fully expect they’ll be non-tariff barriers that will protect a domestic supply chain, and we’ll be part of that. And I think the things that we’ve learned here, you can really take and apply there.

So our goal is to participate in the markets rather than send product in, because I think that’s a very short term business.

James West:    Okay. So you’re basically going to set up a local producer there?

Bruce Linton:  Yeah, for sure. It worked for bottling lines for Coca-Cola as an expansion process. Our intent though is, in most countries, to go in where it’s 100 percent corporate store, which is why in November, we acquired the company that had been our export partner, so we actually have our boots on the ground in Germany to work through the process rather than, you know, a JV and everybody’s not aligned.

James West:    Right. And so what’s the size of the market in Germany for this medical marijuana?

Bruce Linton:  I don’t know, James. There’s about 82 million people, and if the government’s paying for it, do you think marijuana could catch on?

James West:    Mm-hmm. That’s a good point, good point. Now, I saw a report from Arcview Research in the United States just issued yesterday that suggested that in North America, consumers had spent $56 billion on marijuana products in 2006. Do you think that’s a credible number, or do you think that’s conservative? Do you think it’s accurate?

Bruce Linton:  Well, I don’t know. They had a US election, so that might have triggered quite a lot of consumption. But no, I’m being a little bit – that number is an incomprehensible number, really. Like, 56 billion? I don’t know what would also land in that category as total sums spent. Like I have no idea how does that compare to, you know, all of food category or types of pharmaceuticals. It’s a new number to me, but I would almost need to correlate it with some other consumption pattern items to sort of get a perspective on what 56 billion really means.

James West:    Sure, okay. And switching gears a bit here now, we saw a bit of negative press come out surrounding a product recall on Mettrum’s behalf, and that was interpreted by some media outlets as a negative. But what’s your take on that?

Bruce Linton:  Well, you know, I think there’s a system in place, and the system is intended to be sure that everybody follows the rules and the resulting product can be a trusted supply chain. So it is too bad that it happened for Mettrum, and it’s happened for Peace and a few others have had recalls, and we’ve got to see the frequency and scope continue to decrease on those. But we want people to trust the supply chain, and when they do, that gets rid of moonshine, or it gets rid of any other kind of alcoholic absence of the same trust or confidence supply chain, which is really what’s going to make people more comfortable trying and buying a product, not just because it’s not illegal.

So, it happened. Our take on it is, if the system catches the results of not following the rules, then that’s a pretty good system.

James West:    Yeah. You bet. Now, there was an article published by Bloomberg last week which caught my attention as well, that was highlighting the crashing prices of marijuana in the legalized states because of the advent of massive grow-ops that are completely automated driving the price down because there’s an excess of product in the market. Now, to what extent do you think that risk’s happening in Canada, or to what extent might that be Canada’s opportunity given the lower dollar, our lower cost of production which we’ve always had to deal with?

Bruce Linton:  I think the basis of the issue is in America, there’s no filter on who can become a grower effectively. If you can scrape together the capital, you can become a grower. And so there was a very high price. So initially, the price of cannabis in the US states was extremely high, and the transfer price, and then it started to come down because too many people went in because the price was too high. They have just way too many suppliers, so pick a small state, will have more than 1,000 growers. So it’s not just the big growers, it’s the number.

In Canada, it’s a pretty restrictive process to become part of the supply chain, and I think for the next three years or so, there’s probably going to be more of a demand exceeding supply than supply exceeding demand. So I don’t think that’s the issue, and I find in Canada, because we have larger companies, we can actually do a lot more research and vertical integration. When you start to extract from the dry cannabis the oils and start to create those either into medically identified products or branded consumer packaged goods, really, the discussion about the variability of the cost of your base material isn’t as relevant as, do people buy the brands or the indications you’ve gone against, which will probably defend the margin.

James West:    Mm-hmm. Okay, so then, in 2017, what are the big events that are going to happen for Canopy?

Bruce Linton:  Well, I think it’s the sector, right? We’ve got legislation hitting Parliament; what it says and when it times it and how close to the Senate will be relevant. We’ve got Germany, Brazil, which means you really have Europe and South America looking to create opportunities for production and supply and proper medical structures.

We’ve got, in Canopy Health operations, a kickoff to do a number of indications for which we wish to get medical-related intellectual property filings, and so those should become kind of interesting. Last year we went from the sector having 30,000 or 40,000 patients to finishing the year with more than 100,000. And I would think that the pace at which people become comfortable with this as a therapeutic option, probably isn’t slowing. And so you have the base market, is it going to triple again? I don’t know, but certainly growing at quite a substantial rate because of the common discussion and comfort of the topic.

James West:    Right. Right. Okay, and turning back to the States for a moment, Jeff Sessions threatened to become the Attorney General of the United States. With Trump’s inauguration today, is that an opportunity for Canada and a threat to recreational marijuana in the United States, from where you sit?

Bruce Linton:  I think it’s going to keep things pretty scattered and broken in the US, which gives the Canadian MC the chance to just get a lot more substantial knowledge and expertise, which will be helpful for us. And I do think that within Trump’s first term, they will look at medical and they will take a really dim view on rec. I think they’re going to divide the two.

I don’t think Sessions is the only actor you’d want to look at; I think it would be pretty important to keep track of who they put in to run the DEA and what budget they give the DEA, because it’s not had much, and whether or not they end up for the drugs are that takes a different approach than under Obama. Because it wouldn’t take too long for the cost of capital in some of these rec plays in the US to go up quite a lot if the Feds started squeezing it all.

James West:    Right. Now across the board, valuations of Canadian marijuana plays have flattened out a bit since the big enthusiasm, the big lift in November. Do you see that as a reflection of the wait and see attitude of the investment community towards when are we going to see this recreational marijuana on the shelves? Do you think it’s just a sign that the market is fully valued? Or do you think it’s some other factor?

Bruce Linton:  I think there was a pretty good run-up and then they sort of stabilized, and so now I think most folks are starting to take maybe a ‘What’s this going to look like in 6, 12 and 18 months’ rather than ‘If I buy it this morning, will I make some money this afternoon’. And so I don’t feel that’s particularly a bad thing, because there are some folks who probably would like to be in the business and running it and then finish maybe by lunch today, but there’s a handful of us that intend to be creating quite a lot of value in the longer-term businesses. So I do like when I have lots of volume; I don’t need all the shares in my pool to trade every week. There’s some balancing act, and I think we’re probably starting to see a little bit of that, and then it’s not bad, because things can actually build from a bit more analysis and a little less hyperactive trading.

James West:    You bet. Okay, Bruce, let’s leave it there. Very informative as usual. Thanks for your time today.

Bruce Linton:  Thanks, James. Talk soon.

James West:    All right. Bye for now.

Bruce Linton:  Bye.

Press release of the German Hemp Association of 19.01.2017

19 Jan 2017
Today, the Bundestag passed the long-discussed law on the medical use of cannabis. Despite the criticism in detail, the German hemp association sees this as a milestone in the history of German cannabis research and a great advance for patients and doctors.

“The combination of a relatively simple prescription option, a relatively wide range of illnesses and the payment by the health insurance companies makes Germany now one of the world’s leading countries in the field of cannabis as a medicine,” says DHW spokesman Georg Wurth.

Above all, however, the association considers the prevention of self-cultivation by patients to be critical. In many countries, especially in Canada and many states of the USA, self-farming is permitted and there are no reports of negative experiences with this scheme.

“Self-cultivation would not only give the patient access to the entire range of hemp, but would also relieve the health insurance companies,” Georg Wurth is convinced.

The association is also critical about the definition of a “serious disease”. Only in such cases are the health insurance companies reimbursed cannabis medicine. But what is a serious illness? The Federal Institute for Drugs has been for manydifferent diseases granted exemptions for the purchase of cannabis and the use of recognized order, including ADHD, tinnitus, headaches and insomnia. Whether the funds in these cases now take over the costs remains unclear and must be clarified in case of doubt in court.

“We will continue to push for improvements in these details, but we will continue to focus on the development of the cannabis cannabis as a medical device, and we will now focus more on the legalization of cannabis as a consumer and the decriminalization of consumers “Says Georg Wurth.

16 States with Laws Specifically about Legal Cannabidiol (CBD) (as of Mar. 17, 2016)


Cannabidiol (CBD) is one of the 400+ ingredients found in marijuana and is not psychoactive. Many states have passed laws allowing for the use of a CBD extract, usually in oil form, with minimal tetrahydrocannabinol (THC), and often for the treatment of epilepsy or seizures in seriously ill children.

We do not consider passing a CBD-specific law to be the equivalent of making medical marijuana legal because these laws do not legalize use of the marijuana plant for medical purposes. See our resource on the legal medical marijuana states for more information.

1. Alabama

On Apr. 1, 2014, Alabama Governor Robert Bentley signed SB 174 , known as “Carly’s Law,” which allows an affirmative defense against prosecution for CBD possession by people suffering from a debilitating epileptic condition. The law states that “a prescription for the possession or use of cannabidiol (CBD) as authorized by this act shall be provided exclusively by the UAB [University of Alabama at Birmingham] Department for a debilitating epileptic condition.” Since marijuana is illegal under federal laws, doctors are not allowed to write “prescriptions” for it. The states that have legal medical marijuana allow doctors to “recommend” it.

2. Delaware

On June 23, 2015, Delaware Gov. Jack Markell signed Rylie’s Law, SB 90 , which states: “[T]he Department shall issue a registry identification card to a qualifying patient with intractable epilepsy or involuntary muscle contractions that cause slow, repetitive movements or abnormal postures, such as dystonia, who is younger than 18 years of age, but only for the use of medical marijuana oil [that is not more than 7% THC].”

3. Florida

On June 16, 2014, Florida Governor Rick Scott signed SB 1030 into law, which allows the use of non-smoked cannabis oil that is less than 0.8% THC and more than 10% cannabidiol by certain patients with cancer, chronic seizures, or severe muscle spasms. Gov. Scott stated the following in a news release from his office:

“As a father and grandfather, you never want to see kids suffer. The approval of Charlotte’s Web [a low-THC cannabis oil used to treat illnesses such as epilepsy in children] will ensure that children in Florida who suffer from seizures and other debilitating illnesses will have the medication needed to improve their quality of life. I am proud to stand today with families who deserve the ability to provide their children with the best treatment available.”

4. Georgia

On Apr. 16, 2015 Georgia Governor Nathan Deal signed HB 1 (Haleigh’s Hope Act) into law, allowing the use of cannabis oil that is contains no more than 5% THC for the following conditions: seizure disorders, sickle cell anemia, cancer, Crohn’s disease, ALS (Lou Gehrig’s disease), multiple sclerosis, mitocondrial disease and Parkinson’s disease. Deal stated at the signing:

“For the families enduring separation and patients suffering pain, the wait is finally over… Now, Georgia children and their families may return home while continuing to receive much-needed care. Patients such as Haleigh Cox, for whom this bill is named, and others suffering from debilitating conditions can now receive the treatment they need, in the place where they belong: Georgia.”

5. Iowa

On May 30, 2014, Iowa Governor Terry Branstad signed SF 2360 into law, saying “This bill received tremendous support and truly shows the power of people talking to their legislators and to their governor about important issues to them, to their families and to their children.” The bill allows the possession or use of cannabidiol that has less than 3% tetrahydrocannabinol [THC] for the treatment of intractable epilepsy with the written recommendation of a neurologist. The bill states that the cannabidiol must be obtained from an out-of-state source and “recommended for oral or transdermal administration” (non-smoked).

6. Kentucky

On Apr. 10, 2014, Kentucky Governor Steve Beshear signed SB 124 . The law excludes from the definition of marijuana the “substance cannabidiol, when transferred, dispensed, or administered pursuant to the written order of a physician practicing at a hospital or associated clinic affiliated with a Kentucky public university having a college or school of medicine.”

7. Mississippi

On Apr. 17, 2014, Mississippi Governor Phil Bryant signed HB 1231 , “Harper Grace’s Law,” which allows for cannabis extract, oil, or resin that contains more than 15% CBD and less than 0.5% THC. “The CBD oil must be obtained from or tested by the National Center for Natural Products Research at the University of Mississippi and dispensed by the Department of Pharmacy Services at the University of Mississippi Medical Center.” The law also provides an affirmative defense for defendants suffering from a debilitating epileptic condition who accessed the CBD oil in accordance with the requirements set forth in the bill and is effective July 1, 2014.

Governor Bryant released the following statement to the media on Apr. 17, 2014:

“The bill I signed into law today will help children who suffer from severe seizure disorders. Throughout the legislative process I insisted on the tightest controls and regulations for this measure, and I have been assured by the Mississippi Bureau of Narcotics that CBD oil is not an intoxicant. The outcome is a bill that allows this substance to be used therapeutically as is the case for other controlled prescription medications. I remain opposed to any effort that would attempt to legalize marijuana or its derivatives outside of the confines of this bill.”

8. Missouri

On July 14, 2014, Missouri Governor Jay Nixon signed HB 2238 into law, which allows the use of cannabis oil that is at least 5% CBD and less than 0.3% THC for intractable epilepsy. The bill requires a neurologist to determine that the patient did not respond to at least three treatment options to be eligible to use the marijuana extract.

9. North Carolina

On July 3, 2014, North Carolina Governor Pat McCrory signed HB 1220 into law. The bill allows universities to conduct clinical trials using CBD oil that is less than 0.3% THC and at least 10% CBD to be used only for the treatment of intractable epilepsy.

10. Oklahoma

On Apr. 30, 2015, Oklahoma Governor Mary Fallin signed HB 2154 , which allows the use of cannabis oil that is no more than 0.3% THC for the treatment of severe forms of epilepsy. Fallin stated at the signing:

“This bill will help get sick children potentially life-changing medicine. By crafting the legislation in a way that allows for tightly controlled medical studies, we can ensure we are researching possible treatments in a responsible and scientific way. The CBD oil we are studying is a non-intoxicating derivative of marijuana. It is not marijuana, and it is not anything that can make you ‘high.’ This law has been narrowly crafted to support highly supervised medical trials for children with debilitating seizures. It is not a first step towards legalizing marijuana, and I will never support the legalization of marijuana in Oklahoma.”

11. South Carolina

On June 2, 2014, South Carolina Governor Nikki Haley signed S 1035 into law. “Julian’s Law” pertains to people who obtain a written certification signed by a physician “stating that the patient has been diagnosed with Lennox-Gastaut Syndrome, Dravet Syndrome, also known as ‘severe myoclonic epilepsy of infancy’, or any other severe form of epilepsy that is not adequately treated by traditional medical therapies and the physician’s conclusion that the patient might benefit from the medical use of cannabidiol.” Those patients may use CBD oil that is less than 0.9% THC and more than 15% cannabidiol, which is to be provided by the Medical University of South Carolina in a study to determine the effects of CBD on controlling seizures.

12. Tennessee

On May 16, 2014, Tennessee Governor Bill Haslam signed SB 2531 into law. The bill allows the use of cannabis oil containing cannabidiol (CBD) that has less than 0.9% THC “as part of a clinical research study on the treatment of intractable seizures when supervised by a physician practicing at… a university having a college or school of medicine.” The study is authorized for four years.

On May 5, 2015, Governor Haslam signed SB 280 into law. The bill allows the use of CBD oil that is less than 0.9% THC and that is “obtained legally in the United States and outside of” Tennessee. The bill went into effect immediately.

13. Texas

On June 1, 2015, Texas Governor Greg Abbott signed SB 339 , which allows the use of cannabis oil that is no more than 0.5% THC and at least 10% CBD for the treatment of intractable epilepsy. The bill requires patients to get approval from two certified specialists.

Governor Abbot stated: “There is currently no cure for intractable epilepsy and many patients have had little to no success with currently approved drugs. However, we have seen promising results from CBD oil testing and with the passage of this legislation, there is now hope for thousands of families who deal with the effects of intractable epilepsy every day.”

14. Utah

On Mar. 21, 2014, Utah Governor Gary Herbert signed HB 105 , known as “Charlee’s Law,” which allows the use and possession of marijuana extract, under certain conditions, by people with intractable epilepsy who have a statement signed by a neurologist. The extract must be composed of less than 0.3% tetrahydrocannabinol (THC) and at least 15% cannabidiol (CBD) by weight, and may not contain any other psychoactive substance. The law goes into effect on July 1, 2014. The extract must be obtained in a sealed container from a laboratory that is licensed in the state where it was produced, with a label stating the extract’s ingredients and origin, and transmitted by the laboratory to the Utah Department of Health. The Utah Department of Health is required to determine the details of the registration program.

Kristen Stewart of the Salt Lake Tribune wrote in her article “Utah Families Celebrate Passage of Cannabis ‘Charlee’s Law,'” dated Mar. 25, 2014:

“HB105 gives Utahns with epilepsy trial access to a non-intoxicating, seizure-stopping cannabis oil. But it doesn’t take effect until July 1, 2014, and until then, Utahns can’t legally possess cannabis oil.

And obtaining it after that date will still risk violating federal law — and require jumping through a set of still-vaguely defined hoops.

Currently, patients will need to travel to states where medical marijuana is legal and import cannabis oil themselves. Doing so remains technically a violation of federal law.”

15. Virginia

On Feb. 26, 2015, Virginia Governor Terry McAuliffe signed HB 1445 into law. The bill stated: “In any prosecution… involving marijuana in the form of cannabidiol oil… it shall be an affirmative defense that the individual possessed such oil pursuant to a valid written certification… for treatment or to alleviate the symptoms of… intractable epilepsy.” The oil must contain at least 15% CBD and no more than 5% THC.

A Feb. 26, 2015 quote from Gov. McAuliffe posted on his Facebook page stated: “The whole reason I got into politics was to bring about a positive impact in the lives of families across the Commonwealth. This piece of legislation is a tremendous step forward.”

16. Wisconsin

On Apr. 16, 2014, Wisconsin Governor Scott Walker signed AB 726 , which states that “any physician may provide an individual with a hard copy of a letter or other official documentation stating that the individual possesses cannabidiol to treat a seizure disorder if the cannabidiol is in a form without a psychoactive effect.” A release from the Governor’s office characterizes the law as “clearing the way for a new treatment for children suffering from seizure disorders, pending FDA approval.”